Advertisement ADMEcell signs agreement with Advancell - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

ADMEcell signs agreement with Advancell

ADMEcell, an on-demand supplier of cell-based assay kits, has entered into an exclusive agreement with Advancell, Barcelona, Spain, to manufacture and distribute the CacoReady system for the North American market.

According to ADMEcell, the CacoReady system is a new tool designed to optimize the time and costs of evaluating the intestinal absorption of compounds. The kit has been designed to provide a ready-to-use user-friendly kit and suitable for high-throughput automated procedures. It provides users with the differentiated Caco-2 barrier (21-day system), plated on 24- or 96-transwell plates.

Sandy Koshkin, president of ADMEcell, said: “This kit with differentiated Caco-2 cell barriers is an innovation that is being offered in North America for the first time. Our customers gain considerable savings of both cost and time.”